Xinbin Chen
Impact in
- Oncology top 0.2%
- Cancer-related Molecular Pathways
- Cancer Research top 0.5%
Papers in
-
- RNA modifications and cancer 48
- RNA Research and Splicing 31
- Epigenetics and DNA Methylation 28
- Ubiquitin and proteasome pathways 19
- Cell death mechanisms and regulation 15
- DNA Repair Mechanisms 11
- Oncology 118
- Cancer-related Molecular Pathways 111
- Co-authors
- Yingjuan Qian (17 shared papers)Jin Zhang (59 shared papers)Wensheng Yan (32 shared papers)Gang Liu (15 shared papers)Jianhui Zhu (11 shared papers)Yong-Sam Jung (17 shared papers)Jieyuan Jiang (7 shared papers)Carol Prives (4 shared papers)
- Journals
- Journal of Biological Chemistry (31 papers)Oncogene (16 papers)Molecular and Cellular Biology (14 papers)Cancer Research (13 papers)PLoS ONE (9 papers)
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Xinbin Chen
172 papers receiving 9.7k citations
Xinbin Chen's Hit Papers
Peers
Comparison fields: 5 of 133
- Oncology 4.2k
- Cancer Research 1.7k
- Biotechnology 933
- Molecular Biology 7.0k
- Cell Biology 589
Countries citing papers authored by Xinbin Chen
This map shows the geographic impact of Xinbin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinbin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinbin Chen more than expected).
Fields of papers citing papers by Xinbin Chen
This network shows the impact of papers produced by Xinbin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinbin Chen. The network helps show where Xinbin Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xinbin Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 176 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effects of p21 Cip1/Waf1 at Both the G 1 /S and the G 2 /M Cell Cycle Transitions: pRb Is a Critical Determinant in Blocking DNA Replication and in Preventing Endoreduplication Hit paper breakdown → | 1998 | 647 |
| 2 | 2010 | 347 | |
| 3 | The potential tumor suppressor p73 differentially regulates cellular p53 target genes. | 1998 | 284 |
| 4 | 2001 | 251 | |
| 5 | 2004 | 246 | |
| 6 | 2002 | 229 | |
| 7 | 2003 | 224 | |
| 8 | 2006 | 223 | |
| 9 | 2004 | 213 | |
| 10 | 2002 | 171 | |
| 11 | 2011 | 161 | |
| 12 | 1997 | 152 | |
| 13 | 2012 | 147 | |
| 14 | 2000 | 143 | |
| 15 | p53, through p21 (WAF1/CIP1), induces cyclin D1 synthesis. | 1995 | 142 |
| 16 | 1998 | 141 | |
| 17 | 2019 | 140 | |
| 18 | 2015 | 138 | |
| 19 | 2006 | 137 | |
| 20 | 2007 | 131 |
About Xinbin Chen
Xinbin Chen is a scholar working on Molecular Biology, Oncology, Cancer Research, Biotechnology and Genetics, having authored 176 papers that have together received 9.8k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (111 papers), RNA modifications and cancer (48 papers), RNA Research and Splicing (31 papers), Epigenetics and DNA Methylation (28 papers), Cancer Research and Treatments (23 papers), Ubiquitin and proteasome pathways (19 papers), Cell death mechanisms and regulation (15 papers) and DNA Repair Mechanisms (11 papers). The work is most often cited by research in Oncology (4.2k citations), Cancer Research (1.7k citations), Biotechnology (933 citations), Molecular Biology (7.0k citations) and Cell Biology (589 citations). Xinbin Chen has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Yingjuan Qian, Jin Zhang, Wensheng Yan, Gang Liu, Jianhui Zhu, Yong-Sam Jung, Jieyuan Jiang, Carol Prives, Ariane Scoumanne and Yanhong Zhang. Their work appears in journals such as Journal of Biological Chemistry, Oncogene, Molecular and Cellular Biology, Cancer Research and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.